Detection and Treatment of Alzheimer's Disease
Brigham Innovation Hub is a resource center for new and experienced innovators at BWH. Subscribers to the Brigham Innovation Hub blog voted on the health care innovations they believe will have the biggest impact on patient care.
Dana-Farber/Brigham and Women's Cancer Center announces a new quick access program that provides for appointments with an oncologist as soon as the next day for newly-diagnosed adult patients. Request an appointment.
Ranked #5 for cardiac care by US News & World Report, BWH's Heart & Vascular Center reports on the state of innovations here, current clinical trials, quality and patient satisfaction, research funding, and BWH's leadership in the field of heart and vascular care.
Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests, creating a precise "tumor profile" of genetic changes for each patient's cancer that aid in selecting specific therapeutic agents to precisely treat each individual's cancer.
- Evolocumab, a PCSK9 inhibitor, Reduces Cardiovascular Events Research suggests that evolocumab may reduce the number of cardiovascular events.
- Longer Duration Anti-Platelet Therapy is Beneficial for Patients with History of Heart Attack New research finds that ticagrelor use beyond one year reduces risk.